10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The Ebola virus, a member of the Filoviridae family, is responsible for severe and often fatal hemorrhagic fever in humans. First identified in 1976 in the Democratic Republic of Congo, outbreaks have since occurred in various Central African countries. The virus is zoonotic, with bats considered natural reservoirs. Ebola spreads through direct contact with infected bodily fluids and tissues, making healthcare settings particularly vulnerable to transmission. The incubation period is 2 to 21 days, during which individuals may be asymptomatic. Symptoms include fever, severe headache, muscle pain, fatigue, diarrhea, and bleeding - both internal and external. Case fatality rates can be high, ranging from 25% to 90%. Rapid diagnostic tests, PCR, and serological assays are used for diagnosis. Supportive care, including hydration and treatment of specific symptoms, remains the primary approach, as no specific antiviral drugs are approved. Strict infection prevention and control measures are crucial to contain outbreaks, and experimental vaccines have shown promise in preventing Ebola infection.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria